Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Stryker Corporation stock
Learn how to easily invest in Stryker Corporation stock.
Stryker Corporation is a medical devices business based in the US. Stryker Corporation shares (SYK) are listed on the NYSE and all prices are listed in US Dollars. Stryker Corporation employs 46,000 staff and has a trailing 12-month revenue of around $17.9 billion.
How to buy Stryker Corporation stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – SYK. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
What's in this guide?
- SYK shares summary
- Compare share dealing platforms
- Is SYK stock a buy or sell?
- Stock performance over time
- Is SYK suitable for ethical investing?
- Are SYK shares over-valued?
- Stryker Corporation's financials
- How volatile are SYK shares?
- Does Stryker Corporation pay a dividend?
- Have SYK shares ever split?
- Other common questions
Stryker Corporation stock price (NYSE: SYK)Use our graph to track the performance of SYK stocks over time.
Stryker Corporation shares at a glance
|Latest market close||$282.48|
|52-week range||$187.62 - $280.46|
|50-day moving average||$244.48|
|200-day moving average||$225.15|
|Wall St. target price||$258.19|
|Dividend yield||$2.78 (1.18%)|
|Earnings per share (TTM)||$6.43|
Buy Stryker Corporation stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Stryker Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Stryker Corporation price performance over time
|1 week (2023-01-27)||11.14%|
|1 month (2023-01-03)||14.82%|
|3 months (2022-11-03)||37.45%|
|6 months (2022-08-03)||30.84%|
|1 year (2022-02-02)||11.01%|
|2 years (2021-02-03)||20.74%|
|3 years (2020-02-03)||33.47%|
|5 years (2018-02-02)||74.10%|
Is Stryker Corporation stock undervalued or overvalued?
Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stryker Corporation's P/E ratio
Stryker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Stryker Corporation shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Stryker Corporation's PEG ratio
Stryker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.8533. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stryker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stryker Corporation's EBITDA
Stryker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.5 billion.
The EBITDA is a measure of a Stryker Corporation's overall financial performance and is widely used to measure a its profitability.
Stryker Corporation financials
|Revenue TTM||$17.9 billion|
|Operating margin TTM||19.34%|
|Gross profit TTM||$11.3 billion|
|Return on assets TTM||6.19%|
|Return on equity TTM||16.04%|
|Market capitalisation||$96 billion|
TTM: trailing 12 months
Stryker Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Stryker Corporation's total ESG risk score
Total ESG risk: 33.93
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 12/31/2018) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Stryker Corporation's environmental score
Environmental score: 3.06/100
Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Stryker Corporation's social score
Social score: 14.68/100
Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Stryker Corporation's governance score
Governance score: 8.19/100
Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Stryker Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||33.93|
|Total ESG percentile||70.66|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Stryker Corporation share dividends
Dividend payout ratio: 44.72% of net profits
Recently Stryker Corporation has paid out, on average, around 44.72% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.18% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 1.18% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $2.78 per share.
While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.
Stryker Corporation's most recent dividend payout was on 30 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 28 December 2022 (the "ex-dividend date").
Have Stryker Corporation's shares ever split?
Stryker Corporation's shares were split on a 2:1 basis on 16 May 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.
Stryker Corporation share price volatility
Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as $187.6183 up to $280.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.9463. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).
Stryker Corporation overview
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stryker Corporation in the news
Stryker Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Stryker Corporation (NYSE:SYK) Q4 2022 Earnings Call Transcript
Stryker announces 10.7% year-over-year net sales increase
Frequently asked questionsWhat percentage of Stryker Corporation is owned by insiders or institutions?
Currently 1.789% of Stryker Corporation shares are held by insiders and 79.717% by institutions. How many people work for Stryker Corporation?
Latest data suggests 46,000 work at Stryker Corporation. When does the fiscal year end for Stryker Corporation?
Stryker Corporation's fiscal year ends in December. Where is Stryker Corporation based?
Stryker Corporation's address is: 2825 Airview Boulevard, Kalamazoo, MI, United States, 49002 What is Stryker Corporation's ISIN number?
Stryker Corporation's international securities identification number is: US8636671013 What is Stryker Corporation's CUSIP number?
Stryker Corporation's Committee on Uniform Securities Identification Procedures number is: 863667101
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert